Ad
Friday, 20 October 2017
GlaxoSmithKline adult shingles vaccine wins U.S. approval
(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment